LOXO
Loxo Oncology, Inc
LOXO
LOXO
Delisted
LOXO was delisted on the 14th of February, 2019.
141 hedge funds and large institutions have $2.74B invested in Loxo Oncology, Inc in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 50 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 32
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
141
Holding in Top 10
6
Calls
$17.4M
Puts
$17.2M
Top Buyers
| 1 | +$191M | |
| 2 | +$86.4M | |
| 3 | +$77.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$45.4M |
Top Sellers
| 1 | -$63.1M | |
| 2 | -$32.5M | |
| 3 | -$19.7M | |
| 4 |
Renaissance Technologies
New York
|
-$19.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$17.3M |